4.7 Letter

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

Related references

Note: Only part of the references are listed.
Article Hematology

ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia

Veronique Gelsi-Boyer et al.

BRITISH JOURNAL OF HAEMATOLOGY (2010)

Article Oncology

Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations

Hadrian Szpurka et al.

LEUKEMIA RESEARCH (2010)

Article Genetics & Heredity

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Thomas Ernst et al.

NATURE GENETICS (2010)

Letter Oncology

Mutations of ASXL1 gene in myeloproliferative neoplasms

N. Carbuccia et al.

LEUKEMIA (2009)